CD79A and nephrotic syndrome: In a study for the treatment of 24 adult patients with steroid-resistant nephrotic syndrome including two IgA nephroapthies, the dose of tacrolimus was maintained to achieve a trough level of 5–10 ng/ml for the initial 6 months and then decreased to a target trough level of 4–6 ng/ml for another 6 months [28].